Pro Medicus Limited (AU:PME) has released an update.
Pro Medicus Limited reports a record-breaking full-year with a 29% increase in revenue to $161.5 million and a 36.5% rise in net profit to $82.8 million, driven by significant growth in North America which now represents 90% of total revenue. The company’s transaction-based model and new contract wins, such as the $140M deal with Baylor Scott & White, suggest a strong growth trajectory and a sustainable high-margin business. With only 7% of the US market captured, the company sees potential for continued expansion in a broad range of healthcare segments.
For further insights into AU:PME stock, check out TipRanks’ Stock Analysis page.
